Back
Xeris Biopharma Holdings Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
XERS
Xeris Biopharma Holdings
Last Price:
$4.88
Seasonality Move:
47.77%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bearish and XERS is experiencing selling pressure, which indicates risk of future bearish movement.
Xeris Biopharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.42 | Sell |
| 20-day SMA: | 5.15 | Sell |
| 50-day SMA: | 4.24 | Buy |
| 200-day SMA: | 3.22 | Buy |
| 8-day EMA: | 5.26 | Sell |
| 20-day EMA: | 5.07 | Sell |
| 50-day EMA: | 4.47 | Buy |
| 200-day EMA: | 3.44 | Buy |
Xeris Biopharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 49.09 | Sell |
| Chaikin Money Flow: | -1824496 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.13 - 5.61) | Buy |
| Bollinger Bands (100): | (3.04 - 4.54) | Buy |
Xeris Biopharma Holdings Technical Analysis
| Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Xeris Biopharma Holdings Stock
Is Xeris Biopharma Holdings Stock a Buy?
-
Xeris Biopharma Holdings share price is 4.88 while XERS 8-day simple moving average is 5.42, which is a Sell signal.
-
The stock price of XERS is 4.88 while Xeris Biopharma Holdings 20-day SMA is 5.15, which makes it a Sell.
-
Xeris Biopharma Holdings 50-day simple moving average is 4.24 while XERS share price is 4.88, making it a Buy technically.
-
XERS stock price is 4.88 and Xeris Biopharma Holdings 200-day simple moving average is 3.22, creating a Buy signal.
XERS Technical Analysis vs Fundamental Analysis
Buy
56
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy or a Sell?
-
Xeris Biopharma Holdings stock is rated a BuyThe current Xeris Biopharma Holdings [XERS] share price is $4.88. The Score for XERS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Xeris Biopharma Holdings Stock Info
Market Cap:
751.2M
Price in USD:
4.88
Share Volume:
2.8M
Xeris Biopharma Holdings 52-Week Range
52-Week High:
6.07
52-Week Low:
1.69
Buy
56
Xeris Biopharma Holdings (XERS)
is a Buy
Xeris Biopharma Holdings Share Price Forecast
-
What is the Xeris Biopharma Holdings stock price today?The Xeris Biopharma Holdings stock price is 4.88 USD today.
-
Will XERS stock go up or go down?Xeris Biopharma Holdings> share price is forecast to RISE/FALL based on technical indicators
-
Is Xeris Biopharma Holdings overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xeris Biopharma Holdings is not overvalued.
Is Xeris Biopharma Holdings Stock a Buy?
-
Xeris Biopharma Holdings share price is 4.88 while XERS 8-day exponential moving average is 5.26, which is a Sell signal.
-
The stock price of XERS is 4.88 while Xeris Biopharma Holdings 20-day EMA is 5.07, which makes it a Sell.
-
Xeris Biopharma Holdings 50-day exponential moving average is 4.47 while XERS share price is 4.88, making it a Buy technically.
-
XERS stock price is 4.88 and Xeris Biopharma Holdings 200-day simple moving average is 3.44, creating a Buy signal.
Fundamental Analysis of Xeris Biopharma Holdings
Is Xeris Biopharma Holdings a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.15 per share, and an increase next year of $0.02 per share.
Technical Analysis of Xeris Biopharma Holdings
Should I short Xeris Biopharma Holdings stock?
-
XERS Moving Average Covergence Divergence (MACD) indicator is 0.32, suggesting Xeris Biopharma Holdings is a Buy
-
Xeris Biopharma Holdings Relative Strength Index (RSI) is 49.09, which suggest Xeris Biopharma Holdings is oversold
-
The Bollinger Bands (25) for Xeris Biopharma Holdings is (4.13 - 5.61), which suggest Xeris Biopharma Holdings is a Buy
-
The Bollinger Bands (100) for Xeris Biopharma Holdings is (3.04 - 4.54), which suggest Xeris Biopharma Holdings is a Buy
* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.